Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88NS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,675
Award facts
- Contract value 100% obligated
- $23,675.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,675.35 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with a completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, as a major pharmaceutical distributor, regularly fulfills federal medical procurement needs through its extensive contract portfolio with the Defense Logistics Agency and other government healthcare systems. The DLA Troop Support Medical contract vehicle enables the company to supply a broad spectrum of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military treatment facilities and veterans' healthcare programs worldwide. This particular delivery order for Ozempic, a diabetes medication, is representative of the company's capability to efficiently meet government requirements for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F88NS?
SPE2DR26F88NS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F88NS worth?
The government has obligated $23,675 on SPE2DR26F88NS.
Is contract SPE2DR26F88NS an order under another contract?
Yes. SPE2DR26F88NS is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88NS competed?
The extent of competition for SPE2DR26F88NS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award